Tarsus Pharmaceuticals Inc To Discuss Revolutionizing Treatment For Demodex Blepharitis Patients Call Transcript
Good day, and welcome to the Revolutionizing Treatment for Demodex Blepharitis Patients Conference Call. (Operator Instructions) As a reminder, this call may be recorded. I would now like to turn the call over to David Nakasone, Head of Investor Relations. You may begin.
Thank you, Michelle. I would like to draw your attention to Slide 2, which contains our forward-looking language statement. We will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail.
With that, I'd like to turn the call over to Bobby, our President and Chief Executive Officer. Bobby?
Thank you very much, David. So I'm Bobak Azamian. I'm the CEO of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
